New study checks if seizure drug cuts hospital trips
NCT ID NCT06922175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at medical records of 200 adults with uncontrolled focal seizures to see if adding cenobamate to their treatment reduces hospital stays, ER visits, and doctor appointments. Researchers will compare healthcare use before and after starting cenobamate. The goal is to understand if this drug helps lower the burden on patients and the healthcare system.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY WITH UNCONTROLLED FOCAL-ONSET SEIZURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Consorcio Hosp. General Universitario Valencia
RECRUITINGValencia, Spain, Spain
-
Department of Neurology, University Hospital Zurich
RECRUITINGZurich, Switzerland, Switzerland
-
Diakonie Kork, Epilepsiezentrum
NOT_YET_RECRUITINGKork, Germany, Germany
-
Epilepsies - The Royal Wolverhampton NHS Trust
RECRUITINGWolverhampton, UK, United Kingdom
-
Epilepsiezentrums am Neurozentrum des Universitätsklinikum Freiburg
NOT_YET_RECRUITINGFreiburg im Breisgau, Germany, Germany
-
Epilepsy Unit - Neurology Department Valle de Hebron Hospital
RECRUITINGBarcelona, Spain, Spain
-
Epilepsy Unit of the Neurology Department of the Hospital Clínico San Carlos
RECRUITINGMadrid, Spain, Spain
-
Epileptologicum
NOT_YET_RECRUITINGHamburg, Germany, Germany
-
Institute of Neurosciences NHS Greater Glasgow and Clyde
RECRUITINGGlasgow, UK, United Kingdom
-
Kempenhaeghe - Academisch Centrum voor Epilepsie
NOT_YET_RECRUITINGHeeze, Netherlands, Netherlands